AU6828894A - Hiv protease inhibitors - Google Patents

Hiv protease inhibitors

Info

Publication number
AU6828894A
AU6828894A AU68288/94A AU6828894A AU6828894A AU 6828894 A AU6828894 A AU 6828894A AU 68288/94 A AU68288/94 A AU 68288/94A AU 6828894 A AU6828894 A AU 6828894A AU 6828894 A AU6828894 A AU 6828894A
Authority
AU
Australia
Prior art keywords
protease inhibitors
hiv protease
hiv
inhibitors
protease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU68288/94A
Other languages
English (en)
Inventor
Arun K. Ghosh
Sean P McKee
Wayne J. Thompson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of AU6828894A publication Critical patent/AU6828894A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU68288/94A 1993-05-14 1994-05-02 Hiv protease inhibitors Abandoned AU6828894A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6189793A 1993-05-14 1993-05-14
US061897 1993-05-14
PCT/US1994/005128 WO1994026749A1 (fr) 1993-05-14 1994-05-02 Inhibiteurs de la protease de vih

Publications (1)

Publication Number Publication Date
AU6828894A true AU6828894A (en) 1994-12-12

Family

ID=22038853

Family Applications (1)

Application Number Title Priority Date Filing Date
AU68288/94A Abandoned AU6828894A (en) 1993-05-14 1994-05-02 Hiv protease inhibitors

Country Status (2)

Country Link
AU (1) AU6828894A (fr)
WO (1) WO1994026749A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE218541T1 (de) 1992-08-25 2002-06-15 Searle & Co Hydroxyethylaminosulfonamide verwendbar als inhibitoren retroviraler proteasen
US7141609B2 (en) 1992-08-25 2006-11-28 G.D. Searle & Co. α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
US6222043B1 (en) 1995-06-30 2001-04-24 Japan Energy Corporation Methods of preparing novel dipeptide compounds or pharmaceutically acceptable salts thereof
CA2179935C (fr) * 1995-06-30 2010-09-07 Ryohei Kato Compose dipeptidique ou sel de ce dernier acceptable en pharmacie; utilisation en medecine
CA2249747A1 (fr) 1996-12-27 1998-07-09 Tsutomu Mimoto Nouveaux composes de tripeptides et medicaments anti-sida
BRPI0212341B8 (pt) * 2001-09-10 2021-05-25 Janssen R&D Ireland compostos intermediários de inibidores de protease de hiv e processo para preparação dos mesmos
JP2005510467A (ja) * 2001-09-20 2005-04-21 スミスクライン ビーチャム コーポレーション プロテアーゼ阻害剤中間体の調製方法
US7157489B2 (en) * 2002-03-12 2007-01-02 The Board Of Trustees Of The University Of Illinois HIV protease inhibitors
US8173623B2 (en) * 2006-03-29 2012-05-08 Gilead Sciences, Inc. Process for preparation of HIV protease inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340588C (fr) * 1988-06-13 1999-06-08 Balraj Krishan Handa Derive d'aminoacides
CA2032259A1 (fr) * 1989-12-18 1991-06-19 Wayne J. Thompson Inhibiteurs de la protease du vih utiles dans le traitement du sida
WO1993008184A1 (fr) * 1991-10-23 1993-04-29 Merck & Co., Inc. Inhibiteurs de la protease du vih______________________

Also Published As

Publication number Publication date
WO1994026749A1 (fr) 1994-11-24

Similar Documents

Publication Publication Date Title
KR100190517B1 (en) Hiv protease inhibitors
AU9122391A (en) Hiv protease inhibitors
HU9601508D0 (en) Dp-iv-serine protease inhibitors
ZA929869B (en) Hiv protease inhibitors
PH31249A (en) Inhibitors of hiv protease.
AU6135294A (en) Piperazine derivatives as hiv protease inhibitors
AU5069993A (en) Retroviral protease inhibitors
AU6183794A (en) Guanidinyl- or amidinyl-substituted methylamino heterocyclic thrombin inhibitors
AU7963394A (en) Mercaptosulfide metalloproteinase inhibitors
EP0691345A3 (fr) Combinaisons d'inhibiteurs de la protéase d'HIV
AUPM982594A0 (en) HIV protease inhibitors
AU7523194A (en) Tick derived protease inhibitor
AU7131991A (en) Hiv protease inhibiting agents
AU7518694A (en) Retroviral protease inhibitors and combinations thereof
AU7102594A (en) Oligonucleotides which inhibit hiv protease function
AU6828894A (en) Hiv protease inhibitors
AU7132391A (en) Hiv protease inhibitors
AU7732691A (en) Hiv protease inhibitors and processes for their preparation
AU6855594A (en) 9-deazahypoxanthines as pnp inhibitors
AU3735793A (en) Retroviral protease inhibitors
AU7689798A (en) Vif-derived hiv protease inhibitors
EP0575500A4 (en) Hiv protease inhibitors
AU3069192A (en) Hiv protease inhibitors containing guanidine
AU7027494A (en) Elastase inhibitor
AU4111896A (en) Hiv protease inhibitors